ONLINE DATABASE SEARCH - HIV-LS-288-MEMO
1. 42682 HIV-LS-288; PUBMED-HIV-1/27/2004
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors
Englund, JA, Raskino, C, Vavro, C, Palumbo, P, Ross, LL, McKinney, R, Nikolic-Djokic, D, Colgrove, RC, and Baker, CJ
Pediatr Infect Dis J 2004. 23(1): 15-22
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14743040&dopt=abstract
2. 42683 HIV-LS-288; EMBASE-HIV-1/29/2004
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients
Gibellini, Davide, Vitone, Francesca, Gori, Elisa, Placa, Michele La, and Re, Maria Carla
Journal of Virological Methods 2004. 115(2): 183-189
HYPERLINK: http://www.sciencedirect.com/science/article/B6T96-4B52V6P-1/2/b8968ce7f5586ce0141971eb2b98069e
3. 42684 HIV-LS-288; EMBASE-HIV-1/29/2004
Transmission of HIV-1 drug resistance
Tang, Julian W and Pillay, Deenan
Journal of Clinical Virology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJV-4BJ2FS0-2/2/a4535aaa3174ef354b128575ec9659be
4. 42685 HIV-LS-288; WOS-HIV-1/22/2004
The Search for the Cd8(+) Cell Anti-Hiv Factor (Caf)
Levy, JA
Trends in Immunology 2003. 24(12): 628-632
5. 42686 HIV-LS-288; EMBASE-HIV-1/29/2004
Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of - and -D4FC-TP
Murakami, Eisuke, Ray, Adrian S, Schinazi, Raymond F, and Anderson, Karen S
Antiviral Research 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4BH6H5B-1/2/f5c8f70d4b65c90f5a31dd7953d33e6b
6. 42687 HIV-LS-288; PUBMED-HIV-1/27/2004
Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action
Huang, L, Yuan, X, Aiken, C, and Chen, CH
Antimicrob Agents Chemother 2004. 48(2): 663-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14742233&dopt=abstract
7. 42688 HIV-LS-288; EMBASE-HIV-1/29/2004
Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains
Miller, John F, Furfine, Eric S, Hanlon, Mary H, Hazen, Richard J, Ray, John A, Robinson, Laurence, Samano, Vicente, and Spaltenstein, Andrew
Bioorganic & Medicinal Chemistry Letters 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF9-4BH63MS-7/2/b42a0f4892f981972c4f8c5eac036b73
8. 42689 HIV-LS-288; WOS-HIV-1/22/2004
The Causes and Consequences of Hiv Evolution
Rambaut, A, Posada, D, Crandall, KA, and Holmes, EC
Nature Reviews Genetics 2004. 5(1): 52-61
9. 42690 HIV-LS-288; EMBASE-HIV-1/29/2004
Synthesis and anti-HIV-1 activity of 4-[4-(4,6-bisphenylamino-[1, 3 and 5]triazin-2-ylamino)-5-methoxy-2-methylphenylazo]-5-hydroxynaphthalene-2,7-disulfonic acid and its derivatives
Naicker, Kannan P, Jiang, Shibo, Lu, Hong, Ni, Jiahong, Boyer-Chatenet, Louise, Wang, Lai-Xi, and Debnath, Asim K
Bioorganic & Medicinal Chemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4BF0CC2-2/2/05f8201f9061394d97347e8b811489e8
10. 42691 HIV-LS-288; PUBMED-HIV-1/27/2004
Anti-viral cyclam macrocycles : rapid zinc uptake at physiological pH
Paisey, SJ and Sadler, PJ
Chem Commun (Camb) 2004(3): 306-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14740050&dopt=abstract
11. 42692 HIV-LS-288; WOS-HIV-1/22/2004
A Single Injection of Recombinant Measles Virus Vaccines Expressing Human Immunodeficiency Virus (Hiv) Type 1 Clade B Envelope Glycoproteins Induces Neutralizing Antibodies and Cellular Immune Responses to Hiv
Lorin, C, Mollet, L, Delebecque, F, Combredet, C, Hurtrel, B, Charneau, P, Brahic, M, and Tangy, F
Journal of Virology 2004. 78(1): 146-157
12. 42693 HIV-LS-288; PUBMED-HIV-1/27/2004
Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells
Nishitsuji, H, Ikeda, T, Miyoshi, H, Ohashi, T, Kannagi, M, and Masuda, T
Microbes Infect 2004. 6(1): 76-85
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14738896&dopt=abstract
13. 42694 HIV-LS-288; PUBMED-HIV-1/27/2004
Anti-AIDS Agents. 52. Synthesis and Anti-HIV Activity of Hydroxymethyl (3'R,4'R)-3',4'-Di-O-(S)-camphanoyl-(+)-cis-khellactone Derivatives
Xie, L, Yu, D, Wild, C, Allaway, G, Turpin, J, Smith, PC, and Lee, KH
J Med Chem 2004. 47(3): 756-760
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14736256&dopt=abstract
14. 42695 HIV-LS-288; WOS-HIV-1/22/2004
Mechanistic Studies of the Separation of an Hiv Protease Inhibitor From Its Piperazine Diastereomer by Reversed Phase High Performance Liquid Chromatography
Wu, N, Gauthier, DR, Dovletoglou, A, and Yehl, PM
Journal of Liquid Chromatography & Related Technologies 2003. 26(20): 3343-3355
15. 42696 HIV-LS-288; PUBMED-HIV-1/27/2004
Synthesis and Antiviral Activity of (Z)- and (E)-2,2-[Bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: Second-Generation Methylenecyclopropane Analogues of Nucleosides(1)
Zhou, S, Breitenbach, JM, Borysko, KZ, Drach, JC, Kern, ER, Gullen, E, Cheng, YC, and Zemlicka, J
J Med Chem 2004. 47(3): 566-575
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14736238&dopt=abstract
16. 42697 HIV-LS-288; PUBMED-HIV-1/27/2004
Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor
Segal, DJ, Gonclaves, J, Eberhardy, S, Swan, CH, Torbett, BE, and Barbas, CF 3rd
J Biol Chem 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14734553&dopt=abstract
17. 42698 HIV-LS-288; PUBMED-HIV-1/27/2004
Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well tolerated
Portsmouth, S, Imami, N, Pires, A, Stebbing, J, Hand, J, Nelson, M, Gotch, F, and Gazzard, BG
HIV Med 2004. 5 (1): 26-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14731166&dopt=abstract
18. 42699 HIV-LS-288; EMBASE-HIV-1/29/2004
Prognostic value of proliferative responses to HIV-1 antigen in chronically HIV-infected patients under antiretroviral therapy
Mohm, JM, Rump, J-A, Schulte-Monting, J, and Schneider, J
Journal of Clinical Virology 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6VJV-4BJ2FS0-1/2/56a793c0b0f5ad6348726ea0eb0e58d0
19. 42700 HIV-LS-288; EMBASE-HIV-1/29/2004
Methylene blue photoinactivation of RNA viruses
Floyd, Robert A, Schneider, Jr JEdward, and Dittmer, Dirk P
Antiviral Research 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T2H-4B8K7CB-1/2/db66fa58b1acf404e4923d96d0b5453e
20. 42701 HIV-LS-288; WOS-HIV-1/22/2004
Hiv-1 Viremia Prevents the Establishment of Interleukin 2- Producing Hiv-Specific Memory Cd4(+) T Cells Endowed With Proliferative Capacity
Younes, SA, Yassine-Diab, B, Dumont, AR, Boulassel, MR, Grossman, Z, Routy, JP, and Sekaly, RP
Journal of Experimental Medicine 2003. 198(12): 1909-1922
21. 42702 HIV-LS-288; PUBMED-HIV-1/27/2004
Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients
Justesen, US, Andersen, AB, Klitgaard, NA, Brosen, K, Gerstoft, J, and Pedersen, C
Clin Infect Dis 2004. 38(3): 426-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14727216&dopt=abstract
22. 42703 HIV-LS-288; PUBMED-HIV-1/27/2004
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA
Ittig, D, Liu, S, Renneberg, D, Schumperli, D, and Leumann, CJ
Nucleic Acids Res 2004. 32(1): 346-53
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14726483&dopt=abstract
23. 42704 HIV-LS-288; EMBASE-HIV-1/29/2004
Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride
Premkumar, A, Wilson, L, Ewart, GD, and Gage, PW
FEBS Letters 2004. 557(1-3): 99-103
HYPERLINK: http://www.sciencedirect.com/science/article/B6T36-4B7PYYM-3/2/8aa04089709330e37ac30f1d4a5e67a4
24. 42705 HIV-LS-288; WOS-HIV-1/22/2004
Mechanistic Basis for Reduced Viral and Enzymatic Fitness of Hiv-1 Reverse Transcriptase Containing Both K65r and M184v Mutations
Deval, J, White, KL, Miller, MD, Parkin, NT, Courcambeck, J, Halfon, P, Selmi, B, Boretto, J, and Canard, B
Journal of Biological Chemistry 2004. 279(1): 509-516
25. 42706 HIV-LS-288; PUBMED-HIV-1/27/2004
Molecular biology of the human immunodeficiency virus: Current and future targets for intervention
Krogstad, P
Semin Pediatr Infect Dis 2003. 14(4): 258-68
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14724791&dopt=abstract
26. 42707 HIV-LS-288; EMBASE-HIV-1/29/2004
Synthesis of 6-arylvinyl analogues of the HIV drugs SJ-3366 and Emivirine
Wamberg, Michael, Pedersen, Erik B, El-Brollosy, Nasser R, and Nielsen, Claus
Bioorganic & Medicinal Chemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4BDW3BR-F/2/a6f2a66f2073bccce730988d223d7b81
27. 42708 HIV-LS-288; PUBMED-HIV-1/27/2004
Three-dimensional quantitative structure-activity relationship analyses of piperidine-based CCR5 receptor antagonists
Song, M, Breneman, CM, and Sukumar, N
Bioorg Med Chem 2004. 12(2): 489-99
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14723967&dopt=abstract
28. 42709 HIV-LS-288; EMBASE-HIV-1/29/2004
Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
Dixit, Narendra M and Perelson, Alan S
Journal of Theoretical Biology 2004. 226(1): 95-109
HYPERLINK: http://www.sciencedirect.com/science/article/B6WMD-4B1WXVT-6/2/577c42c90c67201f88d941a4653ed7ad
29. 42710 HIV-LS-288; PUBMED-HIV-1/27/2004
Synthesis and antiviral evaluation of novel 3'- and 4'-doubly branched carbocyclic nucleosides as potential antiviral agents
Hong, JH
Arch Pharm Res 2003. 26(12): 1109-16
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14723348&dopt=abstract
30. 42711 HIV-LS-288; PUBMED-HIV-1/27/2004
Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes
Schaeffer, E, Soros, VB, and Greene, WC
J Virol 2004. 78(3): 1375-83
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14722292&dopt=abstract
31. 42712 HIV-LS-288; PUBMED-HIV-1/27/2004
Mechanism of HIV-1 Integrase Inhibition by Styrylquinoline Derivatives in Vitro
Deprez, E, Barbe, S, Kolaski, M, Leh, H, Zouhiri, F, Auclair, C, Brochon, JC, Le, Bret M, and Mouscadet, JF
Mol Pharmacol 2004. 65(1): 85-98
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14722240&dopt=abstract
32. 42713 HIV-LS-288; WOS-HIV-1/22/2004
3,5-Di-(Tert-Butyl)-6-Fluoro-Cyclosal-D4tmp - a Pronucleotide With a Considerably Improved Masking Group
Ducho, C, Wendicke, S, Gorbig, U, Balzarini, J, and Meier, C
European Journal of Organic Chemistry 2003(24): 4786-4791
33. 42714 HIV-LS-288; PUBMED-HIV-1/27/2004
Application of CoMFA and CoMSIA 3D-QSAR and Docking Studies in Optimization of Mercaptobenzenesulfonamides as HIV-1 Integrase Inhibitors
Kuo, CL, Assefa, H, Kamath, S, Brzozowski, Z, Slawinski, J, Saczewski, F, Buolamwini, JK, and Neamati, N
J Med Chem 2004. 47(2): 385-399
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14711310&dopt=abstract
34. 42715 HIV-LS-288; PUBMED-HIV-1/27/2004
Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication
Ramratnam, B, Ribeiro, R, He, T, Chung, C, Simon, V, Vanderhoeven, J, Hurley, A, Zhang, L, Perelson, AS, Ho, DD, and Markowitz, M
J Acquir Immune Defic Syndr 2004. 35(1): 33-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14707789&dopt=abstract
35. 42716 HIV-LS-288; WOS-HIV-1/22/2004
No Clinically Significant Pharmacokinetic Interactions Between Voriconazole and Indinavir in Healthy Volunteers
Purkins, L, Wood, N, Kleinermans, D, and Love, ER
British Journal of Clinical Pharmacology 2003. 56: 62-68
36. 42717 HIV-LS-288; PUBMED-HIV-1/27/2004
SC35 and hnRNP A/B proteins bind to a juxtaposed ESE/ESS element to regulate HIV-1 tat exon 2 splicing
Zahler, AM, Damgaard, CK, Kjems, J, and Caputi, M
J Biol Chem 2003
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14703516&dopt=abstract
37. 42718 HIV-LS-288; WOS-HIV-1/22/2004
Synthesis of Novel Carboacyclic Nucleosides With Vinyl Bromide Moiety as Open-Chain Analogues of Neplanocin a
Choi, MH and Kim, HD
Archives of Pharmacal Research 2003. 26(12): 990-996
38. 42719 HIV-LS-288; WOS-HIV-1/25/2004
Enhanced uptake of a heterologous protein with an HIV-1 tat protein transduction domains (PTD) at both termini
Ryu, J, Han, K, Park, J, and Choi, SY
MOL CELLS 2003. 16(3): 385-391
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187603900017
39. 42720 HIV-LS-288; WOS-HIV-1/25/2004
Induction of intercellular adhesion molecule-1 on human brain endothelial cells by HIV-1 gp120: Role of CD4 and chemokine coreceptors
Stins, MF, Pearce, D, Di Cello, F, Erdreich-Epstein, A, Pardo, CA, and Kim, KS
LAB INVEST 2003. 83(12): 1787-1798
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187673800011
40. 42721 HIV-LS-288; WOS-HIV-1/25/2004
Improved inhibition of human immunodeficiency virus type 1 replication by intracellular co-overexpression of TAR and RRE decoys in tandem array
Lee, SW
J MICROBIOL 2003. 41(4): 300-305
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187732200006
41. 42722 HIV-LS-288; WOS-HIV-1/25/2004
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine
Kempf, DJ, King, MS, Bernstein, B, Cernohous, P, Bauer, E, Moseley, J, Gu, K, Hsu, A, Brun, S, and Sun, E
J INFECT DIS 2004. 189(1): 51-60
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187723300008
42. 42723 HIV-LS-288; WOS-HIV-1/25/2004
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies - Implications for acquired immunodeficiency syndrome vaccine
Ferrantelli, F, Kitabwalla, M, Rasmussen, RA, Cao, C, Chou, TC, Katinger, H, Stiegler, G, Cavacini, LA, Bai, Y, Cotropia, J, Ugen, KE, and Ruprecht, RM
J INFECT DIS 2004. 189(1): 71-74
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187723300010
43. 42724 HIV-LS-288; WOS-HIV-1/25/2004
Isolation, structure and HIV-1 integrase inhibitory activity of exophillic acid, a novel fungal metabolite from Exophiala pisciphila
Ondeyka, JG, Zink, DL, Dombrowski, AW, Polishook, JD, Felock, PJ, Hazudp, DJ, and Singh, SB
J ANTIBIOT 2003. 56(12): 1018-1023
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187623700006
44. 42725 HIV-LS-288; WOS-HIV-1/25/2004
Polyriboinosinic polyribocytidylic acid [poly(I : C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8(+) cytotoxic T lymphocytes
Fujimoto, C, Nakagawa, Y, Ohara, K, and Takahashi, H
INT IMMUNOL 2004. 16(1): 55-63
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187826800007
45. 42726 HIV-LS-288; WOS-HIV-1/25/2004
Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection
Huigen, MCDG, Kamp, W, and Nottet, HSLM
EUR J CLIN INVEST 2004. 34(1): 57-66
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187892600009
46. 42727 HIV-LS-288; WOS-HIV-1/25/2004
CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives
Imamura, S, Ishihara, Y, Hattori, T, Kurasawa, O, Matsushita, Y, Sugihara, Y, Kanzaki, N, Iizawa, Y, Baba, M, and Hashiguchi, S
CHEM PHARM BULL 2004. 52(1): 63-73
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187736600009
47. 42728 HIV-LS-288; WOS-HIV-1/25/2004
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N
Clemente, JC, Hemrajani, R, Blum, LE, Goodenow, MA, and Dunn, BA
BIOCHEMISTRY-US 2003. 42(51): 15029-15035
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187634900003
48. 42729 HIV-LS-288; WOS-HIV-1/25/2004
Anti-HIV-1 activity and mode of action of mirror image oligodeoxynucleotide analogue of Zintevir
Urata, H, Kumashiro, T, Kawahata, T, Otake, T, and Akagi, M
BIOCHEM BIOPH RES CO 2004. 313(1): 55-61
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187745900010
49. 42730 HIV-LS-288; WOS-HIV-1/25/2004
Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs
Joly, V, Descamps, D, Peytavin, G, Touati, F, Mentre, F, Duval, X, Delarue, S, Yeni, P, and Brun-Vezinet, F
ANTIMICROB AGENTS CH 2004. 48(1): 172-175
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187728500025
50. 42731 HIV-LS-288; WOS-HIV-1/25/2004
Recent advances in anti-HIV pharmacology
Mouscadet, JF and Deprez, E
ACTUAL CHIMIQUE 2003(11-12): 128-134
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187571200022